Sign In

Member Spotlight: Dalgety

When people talk about building a world-class medical cannabis industry in the UK, they often focus on policy, prescribing or patient access. Behind every prescription, however, is the quality and consistency of the medicine itself. For Cannabis Industry Council member Dalgety, that has been their mission from day one. Founded in 2019 and fully self-funded, […]

Read More

Member Spotlight: Glass Pharms

The CIC recently visited Glass Pharms’ UK cultivation facility to spotlight the company’s approach to producing consistent, pharmaceutical-grade medical cannabis in the UK and to better understand how domestic cultivation is helping shape the future of patient access.  During the visit, the Glass Pharms team shared insight into the company’s growing processes, sustainability initiatives, and […]

Read More

New Research Estimates UK Medical Cannabis Patient Numbers at 60,000–75,000 Active Patients

New research published by Plantz and Cannavec.ai offers a fresh estimate of the size of the UK’s medical cannabis patient population, highlighting both the rapid growth of the sector and the continued lack of official nationwide patient reporting. According to the research, there are currently an estimated 60,000–75,000 active medical cannabis patients in the UK as […]

Read More

Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition. Taking place at The Barbican on […]

Read More

What Patients Need to Know About Travelling with Medical Cannabis in 2026

For UK patients prescribed medical cannabis, travel means navigating a legal grey area that can change dramatically depending on where you’re going. That’s exactly why the Cannabis Industry Council (CIC) has released its new guide, Travelling with Medical Cannabis: a practical, no-nonsense resource designed to help patients avoid common pitfalls and travel with confidence. Why […]

Read More

CIC MasterClass, 1st April, 2026 – Wrap Up

Our first CIC MasterClass of 2026 at the Irwin Mitchell offices in London was a huge success! This was an incredibly strong room and a great reminder of how much the UK cannabis space is starting to sharpen. A big thank you to Irwin Mitchell and Glass Pharms for presenting this CIC MasterClass session, and […]

Read More

Cannabis Europa London 2026 reveals programme as European market confronts its most consequential year

Cannabis Europa London 2026, taking place on 26–27 May at The Barbican, has published its full programme for what is set to be the most consequential edition of the event to date. The two-day conference brings together more than 1,750 investors, operators, policymakers, and healthcare professionals to examine the structural shifts defining the European cannabis […]

Read More

The International Cannabis Business Conference Returns to Berlin for 2026

Authored by: The Cannabis Industry Council Germany’s legal cannabis industry continues to set the pace for Europe, and in April 2026, the global sector will once again converge in the capital for the International Cannabis Business Conference (ICBC) Berlin 2026. Taking place from 13th-15th of April at the iconic Estrel Berlin Hotel, ICBC remains Europe’s […]

Read More

CIC Welcomes New Police Guidance on Prescribed Medicinal Cannabis

The Cannabis Industry Council welcomes the publication of new guidance for police officers and staff on prescribed medicinal cannabis, developed by the Association of Police Controlled Drug Liaison Officers (APCDLO) and endorsed across policing bodies For patients, clarity around the law is not a “nice to have”, it is essential. Too many people who are […]

Read More

US Federal Cannabis Rescheduling: What’s Changed and Why It Matters

In December 2025, President Trump signed an Executive Order directing U.S. federal agencies to move forward with the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. While this does not immediately change the legal status of cannabis at a federal level, it represents a significant moment in the ongoing […]

Read More